Bharat Biotech released a factsheet in which they haveexplained who should take the vaccine and who should skip it amid risingconcerns due to pending Phase 3 results.
Bharat Biotech said, people with weaker immunity, who arepreviously on medication and allergies should skip taking two dose Covaxinprepared by them.
The government had earlier said that patients who are onimmuno-uppressants or have immune deficiency could take the vaccine but theresponse would be less effective in such individuals. Immune suppressed arethose people who are cancer patients and undergoing chemotherapy and similarlyHIV patients are also at greater risk.
Prime Minister Narendra Modi launched nationwideinoculation drive against Covid-19 with two vaccine candidates approved by theDrugs and Controller General of India (DCGI), on January 16.
While Covaxin is an indigenous vaccine prepared byHyderabad based Bharat Biotech, Covishield is prepared by Serum Institue ofIndia that is an equivalent of Oxford-Astrazeneca vaccine.
Meanwhile, some 580 adverse reactions were reportedyesterday and two deaths were reported from Uttar Pradesh and Karnataka.However, it has been said that these are not linked to the vaccines.
In its factsheet, Bharat Biotech has mentioned that thosewho have fever, bleeding disorder or who have thinner blood or have a historyof allergies or women who are expecting or breastfeeding should not be givenCovaxin shot.
Similarly, both the vaccines (Covishield and Covaxin)should not be mixed or these are not interchanged.
The side-effects of the vaccine include pain, swellingand itching where the vaccine has been injected on the body, rashes, nausea,weakness, fever among others.
People who are taking the Covaxin are been advised by theexperts to reveal their medical histories.
Bharat Biotech clarified, "Additionally, there is aremote chance that the Covaxin could cause a severe allergic reaction. For thisreason, your vaccination provider will ask you to stay for 30 minutes aftereach dose of vaccination at the place where you received your vaccine formonitoring after vaccination."